Using LLMs to Detect Regulatory Contradictions in SOPs

Companies struggle to keep internal Standard Operating Procedures (SOPs) aligned with global compliance requirements. The FDA, EMA, and other regional bodies issue frequent updates. For pharma and medical device companies, biotech, and healthcare firms, even a small contradiction between an SOP and a regulation can lead to inspection findings, warning letters, or delays.

Large language models like GPT-4 are changing how compliance teams review SOPs. Beyond generating text, these systems can analyze regulatory documents, cross-check internal SOPs, and flag contradictions that manual review misses.

This post covers how LLMs work in compliance review, current use cases, how tools fit together, and what teams should watch out for.

The Role of SOPs in Regulatory Compliance

SOPs are the foundation of compliance. They define how daily operations, safety practices, manufacturing processes, and quality checks get performed. Regulators review SOPs during inspections to confirm they match legal and scientific standards.

SOPs go stale when new laws or guidelines appear:

• A clinical trial documentation SOP may not reflect the latest ICH guidelines.
• A manufacturing SOP may contradict GMP updates on cleaning validation.
• A data privacy SOP may not align with stricter GDPR or AI Act requirements.

Companies typically rely on compliance officers and quality managers to update SOPs. With thousands of documents across multiple regions, the process is slow and error-prone.

Why LLMs Like GPT-4 Are a Meaningful Shift

LLMs process large volumes of unstructured text: regulatory documents, inspection findings, SOPs, and guidelines. Strengths for compliance include:

• Pattern recognition. Detecting mismatched statements between SOPs and regulations.
• Contextual understanding. Identifying contradictions by meaning, not just keywords.
• Automation at scale. Reviewing hundreds of SOPs in less time than a manual team can cover.
• Continuous learning. Updating knowledge as regulations evolve.

An LLM can act as an intelligent first-pass reviewer that scans documents for risks and flags where SOPs deviate from compliance standards.

How LLMs Detect Contradictions in SOPs

LLMs use natural language processing to:

1. Extract key regulatory clauses (for example, requirements from 21 CFR Part 11).
2. Compare SOP text with regulations to find outdated terms or missing steps.
3. Reason about context (a "secure storage" clause may demand stricter encryption than the SOP specifies).
4. Highlight contradictions where two SOPs conflict with each other or with external regulations.
5. Suggest revisions in draft form for compliance officers to review.

Atlas

FDA Inspection Intelligence Digest

We track every 483, EIR, and warning letter the moment it happens. Get the signals before they hit the FDA website.

Subscribe

Key Benefits for Compliance Teams

• Time efficiency. Reviews that took weeks can finish in days.
• Cost savings. Reduced consultant fees and fewer penalties.
• Risk reduction. Early identification of contradictions prevents inspection failures.
• Audit readiness. Regulators are increasingly open to AI-assisted review, when well documented.
• Standardization. SOPs across geographies follow a unified compliance framework.

Practical Use Cases

• Cross-checking against FDA GMP. Running an LLM over hundreds of SOPs to flag clauses that conflict with current CFR requirements.
• Data privacy review. Comparing handling procedures against HIPAA or GDPR language.
• Cross-regional harmonization. Identifying contradictions between site-specific SOPs and corporate quality standards.

Challenges in Adoption

• Data privacy. Feeding sensitive SOPs into external LLMs raises confidentiality issues.
• Accuracy. LLMs generate false positives and can miss subtle contradictions.
• Integration. Linking AI tools with existing Quality Management Systems can be complex.
• Change management. Staff may resist AI-driven review.

Balance automation with human oversight.

Where Atlas Fits

Atlas covers 700,000+ FDA inspections since 2010, 30,000+ 483s and EIRs, and 11,800+ warning letters. When an LLM flags an SOP contradiction, Atlas provides the enforcement context: how has the FDA cited similar language at peer companies, which investigators focus on this area, and what observations are trending.

An LLM detects the contradiction. Atlas shows what the FDA has actually done about it.

Future Expectations for AI in Compliance

• Wider LLM adoption in pharma and biotech compliance workflows through 2027.
• By 2030, regulatory bodies may formally recognize AI-assisted reviews as part of compliance documentation.
• Global harmonization: AI will help companies comply with overlapping frameworks like FDA, EMA, and the AI Act simultaneously.
• Predictive compliance: future systems will flag risks before they materialize, not just detect contradictions.